Posts By :

charlotte.duncan

Lysogene announces that no takeover offer was filed
Lysogene announces that no takeover offer was filed 150 150 Lysogene

Paris, France — 14 April 2023 at 06:00 pm CET — Lysogene (FR0013233475 – LYS), a…

Lysogene announces the extension of deadline for the submission of offers
Lysogene announces the extension of deadline for the submission of offers 150 150 Lysogene

Paris, France — 24 March 2023 at 08:00 am CET — Lysogene (FR0013233475 – LYS), a…

Lysogene announces the extension of deadline for the submission of offers
Lysogene announces the extension of deadline for the submission of offers 150 150 Lysogene

Paris, France — 16 February 2023 at 06:00 pm CET — Lysogene (FR0013233475 – LYS), a…

Lysogene Appoints Côme de La Tour du Pin as Chief Financial Officer
Lysogene Appoints Côme de La Tour du Pin as Chief Financial Officer 150 150 Lysogene

Paris, France — 03 February 2023 at 6:00 pm CET — Lysogene (FR0013233475 – LYS), a…

Lysogene COVID-19 update

Find out More

Lysogene is developing therapies for children with CNS diseases.

Delivering Gene Therapy’s Promise

About Us
Our Science
Meet the Team
Diseases
Resources

Contact Us
Careers
Transparency
Compassionate Use Policy

©2022 Lysogene. All rights reserved.

Cookie Policy
Privacy Policy
Legal Notice

Get In Touch

Don’t hesitate to contact us if you need more help.

    Start Typing